• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Recap From the 2023 SDPA Annual Fall Conference


If you weren’t able to attend the 2023 Society of Dermatology Physicians Fall Conference or want to review our latest coverage and interviews, our full recap has you covered.

andreykr/Adobe Stock
andreykr/Adobe Stock

Previewing the 2023 SDPA Annual Fall Dermatology Conference: What to Expect

The conference aimed at providing dermatology physician assistants with the latest in the field begins tomorrow in Nashville, Tennessee.

POLL: What Topic Are You Most Looking Forward to at SDPA Fall 2023?

Click here to answer today's poll.

Plan Your Trip: What to do While Visiting Nashville for SDPA Fall 2023

When sessions, late-breaking research, and more conclude at SDPA Fall 2023, there is no shortage of things to do in Nashville.

Jane Mast, PhD, DMSc, MPAS: Having a Passion for Patients

Mast spoke with Dermatology Times about her conference workshop, what she's looking forward to ahead of this week's SDPA conference, and the importance of always maintaining a passion for patients.

Hyaluronic Acid Filler Demonstrates Efficacy in Moderate and Severe Infraorbital Hollows

Re-treatment 12 months after initial hyaluronic acid filler treatment resulted in further infraorbital rejuvenation.

More Than Half of Adults With Moderate to Severe AD Report Conditions That May Influence Their Selection of JAK Inhibitors

The most common conditions or concerns patients reported having that may influence their selection of a JAK inhibitor included an increased risk of MACE and an age above 65 years.

Renata Block, MMS, PA-C: When We Collaborate, The Patient Wins

Renata Block, MMS, PA-C, delves into the important and ever-evolving role of physician assistants in dermatology.

IDP-126 Gel Led to Improvements in Erythema Among Black Patients With Acne

A post hoc analysis evaluated the safety, efficacy, and tolerability of IDP-126 gel in Black patients with moderate to severe acne, of which there are limited data and literature describing its outcomes in this patient population.

Orit Markowitz, MD: Cutting Edge Dermatology - Without Cutting the Skin

Orit Markowitz, MD, discusses pearls her SDPA fall conference sessions, "Melanoma Diagnosis, Outcomes and Survival," and "Advanced Conditions."

2023 SDPA Fall Conference Recap: Day 1

Catch up on coverage from the first day of the 2023 SDPA Fall Dermatology Conference.

Robyn Siperstein, MD, FAAD: Initiating a Patient-First Dialogue in Cosmetic Dermatology

Robyn Siperstein, MD, FAAD, reviews highlights and takeaways from her SDPA Fall 2023 sessions discussing considerations in cosmetic dermatology, thought-changing research in aesthetics, and more.

Secukinumab Demonstrates Efficacy in Reducing Tunnels Associated With Hidradenitis Suppurativa

More than 80% of patients did not experience an increase in number of draining tunnels associated with HS by week 52.

Enhancing the Patient Experience Through Addressing Pain Points and “Being Extra”

Joe Cari, MPAS, PA-C, spoke to SDPA Fall Conference attendees about the importance of maximizing the patient journey from arrival to check out and beyond.

Modified Irritation Study Reveals Tazarotene 0.045% Less Irritating Than Trifarotene, Adapalene

Tazarotene was significantly less irritating to the skin than trifarotene and numerically less irritating than adapalene, according to a poster presented at SDPA Fall 2023.

4 Tips and Considerations for Selecting a Systemic Treatment for Your Patients With Psoriasis

Douglas DiRuggiero, DMSc, PA-C, presented a comprehensive session at the SDPA fall conference on treatment selection for patients with psoriasis.

Investigation of Risk Factors for Metastatic Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients

A poster presented at SDPA’s fall conference revealed key insights into the importance of close monitoring and preventative measures in patients with cSCC.

2023 SDPA Fall Conference Recap: Day 2

Catch up on coverage from the second day of the 2023 SDPA Fall Dermatology Conference.

Lisa Swanson, MD, PhD: Clinical Pearls in Pediatric Dermatology

Lisa Swanson, MD, PhD, delves into clinical pearls from her SDPA fall conference sessions on infantile hemangiomas and challenging cases in pediatric dermatology.

Tapinarof Cream 1% Led to Rapid Improvements in Itch for Adults With Mild to Severe Plaque Psoriasis

Once daily application of tapinarof cream 1% rapidly improved itch in adult patients with varying plaque psoriasis diseases severity, according to a poster presented at SDPA’s fall conference.

Taking a Comprehensive Approach to Common Vulvar Dermatoses

Olushola Akinshemoyin Vaughn, MD, shared clinical pearls from her work in a vulvar dermatology clinic at the 2023 SDPA fall conference.

Reviewing Common Facial, Bodily Pigmented Dermatoses in Varying Clinical Presentations

Rebecca Vasquez, MD, presented a session on common, overlapping, and complex pigmented dermatoses.

Ami Greene, MD: Tools and Tricks for Beginner to Intermediate Dermoscopy

Ami Greene, MD, discusses her beginner and intermediate SDPA fall conference sessions on dermoscopy.

Case Series Finds No Serious Adverse Events as a Result of Live Attenuated Vaccines in Children Treated With Dupilumab

Investigators said that additional, larger studies are needed to assess the safety of live attenuated vaccine administration for pediatric AD patients being treated with dupilumab.

2023 SDPA Fall Conference Recap: Day 3

Catch up on coverage from the third day of the 2023 SDPA Fall Dermatology Conference.

Study Reveals HCPs Underestimate Burden of Disease Associated With Seborrheic Dermatitis

The study was presented in a poster at the 2023 SDPA Fall Conference in Nashville, TN.

Understanding Itchy Dermatoses: Pearls and Best Practices

Ted Rosen, MD, presented a session comprehensively discussing common dermatoses characterized by itch and pruritus.

Mark Lebwohl, MD: The Evolving Treatment Landscape of IL-17 Inhibitors

Mark Lebwohl, MD, spoke with Dermatology Times about his talk on IL-17 inhibitors.

Individualized Treatment Considerations for Adult Women With Acne

Allison Arthur, MD, discussed the importance of tailoring a treatment plan for adult women with acne vulgaris that best suits their lifestyle and current needs.

2023 SDPA Fall Conference Recap: Day 4

Catch up on coverage from the fourth and final day of the 2023 SDPA Fall Dermatology Conference.

POLL: What Did You Take Away From SDPA Fall 2023?

Click here to answer today's poll.

Make sure to keep up to date with the latest in coverage from the conference and subscribe to Dermatology Times to receive daily email updates.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.